Author

Youssef M. Eltalkhawy

Joint Research Center for Human Retrovirus Infection, Kumamoto UniversityORCID 0000-0002-5398-4205Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Immunology· 1 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

Naofumi Takahashi· 2 shared Shinya SuzuiD· 2 shared Akira OnoiD· 1 shared Hideki NakayamaiD· 1 shared Hidenobu MizunoiD· 1 shared Hiroshi IshiiiD· 1 shared Hiroshi OhnoiD· 1 shared Hiroyuki GatanagaiD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMolecular Biology

Naofumi Takahashi

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Identification of M-Sec as a unique cellular regulator of CSF-1 receptor activation

Randa A. Abdelnaser, Masateru Hiyoshi, Naofumi Takahashi, Youssef M. Eltalkhawy, Hidenobu Mizuno, Shunsuke Kimura, Koji Hase, Hiroshi Ohno, Kazuaki Monde, Akira Ono, Shinya Suzu

This study identifies M-Sec as a regulator of CSF-1 receptor activation by promoting Fms aggregate formation through PIP2 binding.

Life Science Alliance · Feb 12, 2025Peer-reviewedMolecular Biology

CD34-positive monocytes are highly susceptible to HIV-1

Naofumi Takahashi, Osamu Noyori, Yoshihiro Komohara, Youssef M. Eltalkhawy, Masatoshi Hirayama, Ryoji Yoshida, Hideki Nakayama, Marcelo J. Kuroda, Takushi Nomura, Hiroshi Ishii, Tetsuro Matano, Hiroyuki Gatanaga, Shinichi Oka, Masafumi Takiguchi, Shinya Suzu

This study identifies CD34+ monocytes as highly susceptible to HIV-1 infection, showing they harbor more proviral DNA and express higher HIV-1 receptors despite cART.

bioRxiv · Feb 26, 2024 · PreprintImmunology